MedKoo Cat#: 464183 | Name: Kinetensin TFA salt
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Kinetensin is a nonapeptide that has been found in pepsin-treated human plasma. It binds to neurotensin receptors in HT-29 cells and mouse brain (Kis = 1,396 and 149.6 nM, respectively, in radioligand binding assays) but does not induce the accumulation of intracellular calcium in HT-29 cells (EC50 = >10,000 nM). It induces histamine release in isolated rat peritoneal mast cells with an EC50 value of approximately 10 µM. Intradermal administration of kinetensin induces vascular permeability in rats.

Chemical Structure

Kinetensin TFA salt
Kinetensin TFA salt
CAS#unknown

Theoretical Analysis

MedKoo Cat#: 464183

Name: Kinetensin TFA salt

CAS#: unknown

Chemical Formula: C58H86F3N17O13

Exact Mass:

Molecular Weight: 1286.43

Elemental Analysis: C, 54.15; H, 6.74; F, 4.43; N, 18.51; O, 16.17

Price and Availability

Size Price Availability Quantity
5mg USD 350.00 2 Weeks
10mg USD 650.00 2 Weeks
25mg USD 1,150.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
103131-69-7 (free base); Kinetensin TFA salt
Synonym
Kinetensin TFA salt; Kinetensin trifluoroacetate salt; Kinetensin (human) (trifluoroacetate salt); Kinetensin (human) (TFA salt); IARRHPYFL; Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe-Leu;
IUPAC/Chemical Name
L-isoleucyl-L-alanyl-L-arginyl-L-arginyl-L-histidyl-L-prolyl-L-tyrosyl-L-phenylalanyl-L-leucine compound with 2,2,2-trifluoroacetic acid (1:1)
InChi Key
HWZXQUSPWVIRMH-PFYQBJFCSA-N
InChi Code
InChI=1S/C56H85N17O11.C2HF3O2/c1-6-32(4)45(57)52(81)66-33(5)46(75)67-38(15-10-22-63-55(58)59)47(76)68-39(16-11-23-64-56(60)61)48(77)71-42(28-36-29-62-30-65-36)53(82)73-24-12-17-44(73)51(80)70-41(27-35-18-20-37(74)21-19-35)49(78)69-40(26-34-13-8-7-9-14-34)50(79)72-43(54(83)84)25-31(2)3;3-2(4,5)1(6)7/h7-9,13-14,18-21,29-33,38-45,74H,6,10-12,15-17,22-28,57H2,1-5H3,(H,62,65)(H,66,81)(H,67,75)(H,68,76)(H,69,78)(H,70,80)(H,71,77)(H,72,79)(H,83,84)(H4,58,59,63)(H4,60,61,64);(H,6,7)/t32-,33-,38-,39-,40-,41-,42-,43-,44-,45-;/m0./s1
SMILES Code
CC[C@@H]([C@@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N1[C@@H](CCC1)C(N[C@H](C(N[C@H](C(N[C@@H](CC(C)C)C(O)=O)=O)CC2=CC=CC=C2)=O)CC3=CC=C(C=C3)O)=O)=O)CC4=CN=CN4)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)C)=O)N)C.OC(C(F)(F)F)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
to be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
Kinetensin is a nonapeptide that has been found in pepsin-treated human plasma.
In vitro activity:
The peptide kinetensin isolated from pepsin-treated human plasma induced a dose-dependent release of histamine when exposed to rat peritoneal mast cells. Reference: Agents Actions. 1989 Apr;27(1-2):68-71. https://pubmed.ncbi.nlm.nih.gov/2473637/
In vivo activity:
Kinetensin also induced a dose-dependent increase in vascular permeability when injected intradermally into rats. Reference: Agents Actions. 1989 Apr;27(1-2):68-71. https://pubmed.ncbi.nlm.nih.gov/2473637/
Solvent mg/mL mM
Solubility
To be determined 0.0 100.00
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 1,286.43 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Sydbom A, Ware J, Mogard MH. Stimulation of histamine release by the peptide kinetensin. Agents Actions. 1989 Apr;27(1-2):68-71. doi: 10.1007/BF02222201. PMID: 2473637.
In vitro protocol:
1. Sydbom A, Ware J, Mogard MH. Stimulation of histamine release by the peptide kinetensin. Agents Actions. 1989 Apr;27(1-2):68-71. doi: 10.1007/BF02222201. PMID: 2473637.
In vivo protocol:
1. Sydbom A, Ware J, Mogard MH. Stimulation of histamine release by the peptide kinetensin. Agents Actions. 1989 Apr;27(1-2):68-71. doi: 10.1007/BF02222201. PMID: 2473637.
1: Clemens A, Katsoulis S, Nustede R, Seebeck J, Seyfarth K, Morys-Wortmann C, Feurle GE, Fölsch UR, Schmidt WE. Relaxant effect of xenin on rat ileum is mediated by apamin-sensitive neurotensin-type receptors. Am J Physiol. 1997 Jan;272(1 Pt 1):G190-6. doi: 10.1152/ajpgi.1997.272.1.G190. PMID: 9038893. 2: Akunne HC, Demattos SB, Whetzel SZ, Wustrow DJ, Davis DM, Wise LD, Cody WL, Pugsley TA, Heffner TG. Agonist properties of a stable hexapeptide analog of neurotensin, N alpha MeArg-Lys-Pro-Trp-tLeu-Leu (NT1). Biochem Pharmacol. 1995 Apr 18;49(8):1147-54. doi: 10.1016/0006-2952(95)98512-8. PMID: 7748196. 3: Keegan KD, Woodruff GN, Pinnock RD. The pharmacology of neurotensin analogues on neurones in the rat substantia nigra, pars compacta in vitro. Eur J Pharmacol. 1994 Feb 21;253(1-2):131-7. doi: 10.1016/0014-2999(94)90767-6. PMID: 8013539. 4: Hasegawa K, Kar S, Carr BI. Stimulation of hepatocyte DNA synthesis by neurotensin. J Cell Physiol. 1994 Feb;158(2):215-22. doi: 10.1002/jcp.1041580202. PMID: 8106558. 5: Lee J, Park H, Kwon H, Kwon G, Jeon A, Kim HI, Sung BJ, Moon B, Oh HB. One- step peptide backbone dissociations in negative-ion free radical initiated peptide sequencing mass spectrometry. Anal Chem. 2013 Aug 6;85(15):7044-51. doi: 10.1021/ac303517h. Epub 2013 Jul 10. PMID: 23802150. 6: Proniewicz E, Małuch I, Kudelski A, Prahl A. Adsorption of (Phe-h5)/(Phe-d5)-substituted peptides from neurotensin family on the nanostructured surfaces of Ag and Cu: SERS studies. Spectrochim Acta A Mol Biomol Spectrosc. 2020 Dec 5;242:118748. doi: 10.1016/j.saa.2020.118748. Epub 2020 Jul 21. PMID: 32721658.